The latest study has revealed some truly shocking and disturbing information!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The latest study from the Tel Aviv University of Israel has revealed that a variation (South African) of the CCP virus is more likely to affect people who have received a full dose of Pfizer vaccination, than those who haven’t received any!
Though the study, which has not yet been peer-reviewed, stated indications that “the B.1.351 variant of the virus—also known as the novel coronavirus—was found eight times more than individuals who were unvaccinated, or 5.4 percent against 0.7 percent.”
“We found a disproportionately higher rate of the South African variant among people vaccinated with a second dose, compared to the unvaccinated group,” said Adi Stern of Tel Aviv University. “This means that the South African variant is able, to some extent, to break through the vaccine’s protection.”
This item sells for $39.95 on Amazon. Today's special promotion is offering a massive discount on this item. President Trump 2020 Coin (Gold & Silver Plated) - Claim 1 Free OR Claim a Discount + Free Shipping This coin is a symbol of President Trump's victory and success. Get Coin HERE Or Click on the image below.
“Based on patterns in the general population, we would have expected just one case of the South African variant, but we saw eight,” Stern told the Times of Israel. “Obviously, this result didn’t make me happy.” He added, “Even if the South African variant does break through the vaccine’s protection, it has not spread widely through the population.”
“These preliminary findings necessitate close continued attention to the dissemination of this strain in Israel, emphasizing the need for epidemiological monitoring and systematic sequencing, in order to contain further spread of the South African variant in Israel.”
“This means that the Pfizer-BioNtech vaccine, though highly protective, probably does not provide the same level of protection against the South African (B.1.351) variant of the coronavirus,” the study concluded.
The study was helped by Clalit Health Services – one of Israel’s top healthcare providers.
“It is the first in the world to be based on real-world data, showing that the vaccine is less effective against the South Africa variant, compared to both the original virus and the British variant,” said Professor Ran Balicer, director of research at Clalit, according to news reports.
This is definitely a shock – especially for the people who have already received a Pfizer vaccine!